« Back to Record
Bertini, E., Dessaud, E., Mercuri, E., Muntoni, F., Kirschner, J., Reid, C., Lusakowska, A., Deconinck, N., Cuisset, J. M., Abitbol, J.-L., Scherrer, B., Ducray, P. S., Buchbjerg, J., Vianna, E., van der Pol, L. W., Vuillerot, C., Blaettler, T., Fontoura, P., & Olesoxime SMA Phase 2 Study Investigators, (2017). Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet neurology, 16(7), 513-522. doi:10.1016/S1474-4422(17)30085-6
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/262802



